Ferric gluconate (Ferrlecit)
Revision as of 00:58, 29 June 2024 by Warner-admin (talk | contribs) (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information")
General information
Class/mechanism: Iron, which is needed for various biologic processes, including synthesis of hemoglobin and multiple enzymatic processes.[1][2][3]
Route: IV
Extravasation: no information
- 1 mL of Ferrlecit provides 12.5 mg of elemental iron
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.[1]
Patient drug information
History of changes in FDA indication
- 1999-02-18: Approved for treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoetin therapy.
Also known as
- Generic name: sodium ferric gluconate complex in sucrose injection
- Brand name: Ferrlecit